Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Mallinckrodt
Moodys
Harvard Business School
Express Scripts

Last Updated: November 28, 2022

Investigational Drug Information for Indibulin


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Indibulin?

Indibulin is an investigational drug.

There have been 6 clinical trials for Indibulin. The most recent clinical trial was a Phase 1 trial, which was initiated on March 1st 2010.

The most common disease conditions in clinical trials are Neoplasms, Breast Neoplasms, and [disabled in preview]. The leading clinical trial sponsors are Ziopharm, Memorial Sloan Kettering Cancer Center, and [disabled in preview].

Recent Clinical Trials for Indibulin
TitleSponsorPhase
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast CancerMemorial Sloan Kettering Cancer CenterPhase 1/Phase 2
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast CancerZiopharmPhase 1/Phase 2
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid TumorsZiopharmPhase 1/Phase 2

See all Indibulin clinical trials

Clinical Trial Summary for Indibulin

Top disease conditions for Indibulin
Top clinical trial sponsors for Indibulin

See all Indibulin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Mallinckrodt
Moodys
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.